Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-14-059810
Filing Date
2014-10-07
Accepted
2014-10-07 09:15:29
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 v390685_424b3.htm 424B3 1362486
2 GRAPHIC tlogo.jpg GRAPHIC 10041
3 GRAPHIC tpg51a.jpg GRAPHIC 113728
4 GRAPHIC tpg51b.jpg GRAPHIC 49188
5 GRAPHIC tpg52.jpg GRAPHIC 42249
6 GRAPHIC tpg56.jpg GRAPHIC 58276
7 GRAPHIC tpg8a.jpg GRAPHIC 83372
8 GRAPHIC tpg8b.jpg GRAPHIC 42974
  Complete submission text file 0001144204-14-059810.txt   1915394
Mailing Address 142 WEST 57TH STREET SUITE 4A NEW YORK NY 10019
Business Address 142 WEST 57TH STREET SUITE 4A NEW YORK NY 10019 646-367-5905
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-198563 | Film No.: 141144275
SIC: 2834 Pharmaceutical Preparations